Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06)
Not Applicable
- Conditions
- Steroid-sensitive nephrotic syndrome
- Registration Number
- JPRN-C000000379
- Lead Sponsor
- Japanese Study Group of Renal Disease in Children(JSRDC)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.History of relapse. 2.Medical history of allergy or hypersensitivity reactions to mizoribine. 3.Poorly controlled hypertension. 4.Chronic renal dysfunction. 5.Active infectious disease. 6.Severe liver disfunction. 7.History of saireito and immunosupression administration. 8.Pregnancy. 9.Judged inappropriate for this study by the physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relapse-free period
- Secondary Outcome Measures
Name Time Method